Dimerization of G-protein-coupled receptors has been increasingly noted in the regulation of their biological activity. However, its involvement in agonist-induced receptor internalization is not well understood. In this study, we examined the ability of mouse ␦-opioid receptors to dimerize and the role of receptor dimerization in agonist-induced internalization. Using differentially (Flag and c-Myc) epitope-tagged receptors we show that ␦-opioid receptors exist as dimers. The level of dimerization is agonist dependent. Increasing concentrations of agonists reduce the levels of dimer with a corresponding increase in the levels of monomer. Interestingly, morphine does not affect the levels of either form. It has been shown that morphine, unlike other opioid agonists, does not induce receptor internalization. This suggests a relationship between the ability of agonists to reduce the levels of dimer and to induce receptor internalization. The time course of the agonist-induced decrease of ␦-opioid receptor dimers is shorter than the time course of internalization, suggesting that monomerization precedes the agonist-induced internalization of the receptor. Furthermore, we found that a mutant ␦-opioid receptor, with a 15-residue C-terminal deletion, does not exhibit dimerization. This mutant receptor has been shown to lack the ability to undergo agonist-induced internalization. These results suggest that the interconversion between the dimeric and monomeric forms plays a role in opioid receptor internalization.The opioid receptor family, a member of the superfamily of G-protein-coupled receptors (GPCRs), 1 consists of three receptor types: ␦, , and . The opioid receptors transmit the signals induced by binding of opioid peptides and opiate alkaloids, such as morphine. Continuous or repeated exposure to opioid ligands causes decreased sensitivity to the drug and reduced cellular response; this response is regulated by multiple mechanisms. Long-term exposure to opioid ligands causes receptor down-regulation as a result of the receptor degradation (1-4).Short-term treatment with opioid ligands causes rapid loss of receptors from the surface of the cell as a result of the receptor endocytosis (5-7). Both of these effects require the intact Cterminal tail of the receptor (4, 7). Although deletion of the C-terminal tail substantially reduces the extent of both downregulation and rapid internalization, point mutations within this region reduce the extent of internalization without affecting down-regulation, suggesting that these two responses are differentially regulated (7). Different opioid ligands induce different effects on rapid internalization of the opioid receptors. Morphine, unlike most of the opioid agonists, does not induce rapid internalization of the opioid receptors (5, 8). An exact mechanism of the opioid receptor internalization is not known, although it has been suggested that the rapid endocytosis of the receptors is mediated through the classic endocytic pathway (5, 7). Possible events that would precede ...